Xilio Development Inc (XLO) support and resistance · rev $31.3M
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
This page maps Xilio Development Inc (XLO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
XLO currently screens at market cap $55.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new XLO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the XLO quote page for the session range and the stock page for the full model.
Not investment advice.